Health
CRISPR screen identifies genes, drug targets to protect against SARS-CoV-2 infection – EurekAlert
Study demonstrates how changes in human genes can reduce SARS-CoV-2 infection and describes a wide array of genes that have not previously been considered as therapeutic…
IMAGE: Graphical abstract of the Cell study
view more
Credit: Sanjana Lab of New York Genome Center/New York University
NEW YORK, NY (October 26, 2020) – To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome. The team examined which genetic modifications…
-
General24 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General11 hours agoLiberals go back to basics after crawling to year’s end
-
Business16 hours ago3 of the best ASX ETFs to build significant wealth
-
General13 hours agoProtecting victims of explicit AI content online